Scotts Miracle-Gro (SMG) director reports new dividend equivalent rights on Form 4
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
The Scotts Miracle-Gro Company director reports routine equity-based compensation activity. A company director filed a Form 4 disclosing the acquisition of 42 dividend equivalent rights tied to existing deferred stock units (DSUs) or restricted stock units (RSUs) on 12/05/2025. After this transaction, the reporting person holds 150 derivative securities directly. The filing explains that each dividend equivalent right is economically equal to one common share of Scotts Miracle-Gro and vests proportionately with the related DSUs or RSUs, reflecting ongoing alignment of director compensation with shareholder interests rather than a cash transaction.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Candelino Roberto
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Dividend Equivalent Rights | 42 | $0.00 | -- |
Holdings After Transaction:
Dividend Equivalent Rights — 150 shares (Direct)
Footnotes (1)
- [object Object]
FAQ
What insider transaction at Scotts Miracle-Gro (SMG) is disclosed in this Form 4?
The Form 4 reports that a director acquired 42 dividend equivalent rights on 12/05/2025, increasing their holdings of derivative securities related to Scotts Miracle-Gro common shares.
Who is the reporting person in this Scotts Miracle-Gro (SMG) Form 4 and what is their role?
The reporting person is a director of The Scotts Miracle-Gro Company, as indicated by the checked relationship box in the filing.
What are the dividend equivalent rights reported for Scotts Miracle-Gro (SMG)?
The filing states that the dividend equivalent rights accrue on DSU or RSU grants and become exercisable proportionately with those DSUs or RSUs. Each right is the economic equivalent of one common share of Scotts Miracle-Gro.
How many derivative securities does the Scotts Miracle-Gro (SMG) director own after this transaction?
Following the reported transaction, the director beneficially owns 150 derivative securities directly, as shown in Table II of the Form 4.
What type of security is reported in Table II for Scotts Miracle-Gro (SMG)?
Table II identifies the derivative security as Dividend Equivalent Rights, each tied to an underlying common share of The Scotts Miracle-Gro Company.
Does this Scotts Miracle-Gro (SMG) insider transaction involve a Rule 10b5-1 trading plan?
The form includes a checkbox for transactions under a Rule 10b5-1(c) plan, but the excerpt does not show that box marked in connection with this specific dividend equivalent rights transaction.